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Abstract
Objective To examine short and long term time trends in mortality among
patients with early onset (age 0-14 years) and late onset (15-29 years)
type 1 diabetes and causes of deaths over time.
Design Population based nationwide cohort study.
Setting Finland.
Participants All Finnish patients diagnosed as having type 1 diabetes
below age 30 years between 1970 and 1999 (n=17 306).
Main outcome measures Crude mortality, standardised mortality ratios,
time trends, and cumulative mortality.
Results A total of 1338 deaths occurred during 370 733 person years
of follow-up, giving an all cause mortality rate of 361/100 000 person
years. The standardised mortality ratio was 3.6 in the early onset cohort
and 2.8 in the late onset cohort. Women had higher standardised
mortality ratios than did men in both cohorts (5.5 v 3.0 in the early onset
cohort; 3.6 v 2.6 in the late onset cohort). The standardised mortality
ratio at 20 years’ duration of diabetes in the early onset cohort decreased
from 3.5 in the patients diagnosed in 1970-4 to 1.9 in those diagnosed
in 1985-9. In contrast, the standardised mortality ratio in the late onset
cohort increased from 1.4 in those diagnosed in 1970-4 to 2.9 in those
diagnosed in 1985-9. Mortality due to chronic complications of diabetes
decreased with time in the early onset cohort but not in the late onset
cohort. Mortality due to alcohol related and drug related causes increased
in the late onset cohort and accounted for 39% of the deaths during the
first 20 years of diabetes. Accordingly, mortality due to acute diabetic
complications increased significantly in the late onset cohort.
Conclusion Survival of people with early onset type 1 diabetes has
improved over time, whereas survival of people with late onset type 1
diabetes has deteriorated since the 1980s. Alcohol has become an
important cause of death in patients with type 1 diabetes, and the
proportion of deaths caused by acute complications of diabetes has
increased in patients with late onset type 1 diabetes.
Introduction
Despite great advances in diabetes care, type 1 diabetes is still
associatedwithconsiderableprematuremortalityresultingfrom
both acute and chronic complications of diabetes. Most of the
excess late mortality after a disease duration of 20 years has
beenrelatedtorenalcomplicationsandcardiovasculardisease,
1-3
and early mortality has mainly been related to acute
complications such as diabetic ketoacidosis.
4
The age at onset of diabetes may influence the risk of late
complications of diabetes. In particular, patients with onset of
diabetes after age 15 have been observed to have a lower risk
of diabetic nephropathy and end stage renal disease than do
patients diagnosed during adolescence.
5-7 Better long term
survival could thus be expected in people diagnosed as having
diabetes after adolescence. However, most of the studies of
mortality have been done in patients with onset of diabetes in
childhood or the age at onset has not been the focus of the
analyses.
The aim of this study was therefore to investigate short term
and long term time trends in mortality in patients diagnosed as
having early onset (age 0-14 years) and late onset (15-29 years)
type 1 diabetes in Finland, the country with the world’s highest
incidence of type 1 diabetes.
8 9 We also studied the causes of
death to identify reasons for potential changes in mortality
during the first 20 years’ duration of diabetes, as well as the
effect of age at onset and duration of disease on mortality.
Methods
Weidentified17306peoplediagnosedashavingtype1diabetes
below 30 years of age between 1970 and 1999 from the drug
reimbursement register. The diagnosis of type 1 diabetes has
been verified in most (74%) of the patients in previous
studies.
1 2 9-11 All Finnish citizens with certain chronic diseases
such as type 1 diabetes are entitled to full reimbursement of
Correspondence to:V Harjutsalo valma.harjutsalo@helsinki.fi
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2011;343:d5364 doi: 10.1136/bmj.d5364 Page 1 of 11
Research
RESEARCHdrug costs. Because insulin has been free of charge for patients
withdiabetesinFinlandsince1964,allpatientswithpermanent
entitlementtofreeinsulinareenteredinthedrugreimbursement
register. To become eligible for the special reimbursement for
the specified diseases, a patient must send an application with
a certificate from a physician giving the details of the diagnosis
and the treatment for the disease.
The classification of the type of diabetes in the rest of the
patients with diabetes (26%) followed the same procedure as
was used in a previously published study.
11 Briefly, we linked
the data on the patients with permanent entitlement for insulin
to the hospital discharge register maintained by the National
InstituteforHealthandWelfare.Thehospitaldischargeregister
has covered all hospital discharges nationwide since 1972 and
includes up to four discharge diagnoses (international
classification of diseases (ICD) codes) of patients who have
been admitted to a hospital. We excluded cases in the hospital
discharge register with a code indicating possible secondary
diabetes before the diagnosis of diabetes. Such codes were for
certain genetic syndromes, diseases of the exocrine pancreas,
orendocrinopathies.Thecodesinthehospitaldischargeregister
had to be 2500B-2508B (ICD-9) or E10.0-E10.9 or O24.0
(ICD-10) to define the patient as having type 1 diabetes.
Data on vital status and causes of deaths came from the Finnish
cause of death register. We used the data from the hospital
discharge register and also reviewed the death certificates to
verify causes of death and contributing conditions.
Statistical methods
Follow-upstartedfromdiagnosisofdiabetesandendedatdeath
or at the end of 2007. We stratified patients into six groups by
yearofdiagnosis:1970-4,1975-9,1980-4,1985-9,1990-4,and
1995-9. We calculated both crude and standardised mortality
ratios for the entire follow-up period, as well as at 20 years’
durationofdiabetes.Wecalculatedstandardisedmortalityratios
for all patients but also separately for the early onset and late
onset cohorts. We calculated the expected number of deaths by
multiplying the number of person years at risk by 1 year age
specific, calendar year specific, and sex specific mortality rates
in the Finnish background population drawn from the human
mortality database (www.mortality.org/). We split the data into
time at risk for each sex, 1 year age, and calendar year group.
We evaluated the non-linear effect of age at onset and duration
of diabetes by fitting generalised additive models. We did time
trend evaluation of the standardised mortality ratios by using
Poisson regression modelling with the Proc Genmod and
incorporated the non-linear terms identified in the generalised
additive modelling in the parametric models.
We calculated cause specific standardised mortality ratios
covering the first 20 years’ duration of diabetes for deaths due
to ischaemic heart disease (ICD codes 410-414 or I20-I25),
cerebrovasculardisease(430-438orI60-I69orG45),andsuicide
(E95 or X60-X84) on the basis of the underlying cause of death
for the entire follow-up period. We evaluated standardised
mortality ratios for alcohol related deaths (291, 303, 3575A,
4255A, 5353A, 5710–5713, 5770D–F, 5771C–D, E24.4, F10,
F19, G31.2, G62.1, G72.1, I42.6, K29.2, K70, K85.2, K86.0,
Q86.0, X45, X46, X65, X66, Y15, Y16) for the years between
1998 and 2007, as the corresponding data in the background
population were available only for these years. For the
calculationofmortalityratesforalcoholrelatedevents,weused
deaths with a reference to alcohol as an underlying or
contributory cause of death. We used SAS version 9.2 for all
analyses.
Results
All cause mortality
Thestudyincluded17306Finnishpatientsdiagnosedashaving
type 1 diabetes below the age of 30 years in 1970-99, of whom
10 492 were in the early onset cohort and 6814 were in the late
onsetcohort.Themeanlengthoffollow-upwas21.4years,and
the maximum was 37.9 years.
A total of 1338 deaths occurred during 370 733 person years of
follow-up, giving an all cause mortality rate of 361 (95%
confidence interval 342 to 382) per 100 000 person years. Five
hundred and forty-one of the patients who died were from the
earlyonsetcohort,and797werefromthelateonsetcohort.The
crude mortality rate was higher in the late onset cohort than in
theearlyonsetcohort:531per100000personyearsversus245
per100000personyears.However,excessmortalitywaslower
in the late onset cohort when compared with the mortality in
the background population. The standardised mortality ratio
was 3.6 (95% confidence interval 3.3 to 3.9) in the early onset
cohort and 2.8 (2.6 to 3.0) in the late onset cohort. The
corresponding standardised mortality ratios during the first 20
years’ duration of diabetes were 3.1 (2.7 to 3.4) and 2.3 (2.1 to
2.6).
The crude mortality was higher in men in both the early onset
cohort (245 per 100 000 person years) and the late onset cohort
(638 per 100 000 person years). For women, it was 197 per 100
000 person years in the early onset cohort and 353 per 100 000
person years in the late onset cohort. Although the crude
mortality was higher in men, women had higher standardised
mortality ratios: 5.5 (4.8 to 6.3) in the early onset cohort and
3.6 (3.3 to 3.9) in the late onset cohort, compared with 3.0 (2.7
to 3.4) and 2.6 (2.4 to 2.8) for men.
Kaplan-Meier analysis indicated that the overall cumulative
mortality at 35 years’ duration of diabetes was 17.9% (95%
confidence interval 17.0% to 18.8%). In the early onset cohort,
the 20 year cumulative mortality in the groups diagnosed in
1970-4, 1975-9, 1980-4, and 1985-9 was 4.7% (3.7% to 5.8%),
4.3% (3.3% to 5.2%), 3.6% (2.8% to 4.5%), and 2.7% (1.9%
to 3.4%) (fig 1⇓, top). However, the follow-up time of the last
group had not yet reached 20 years.
In contrast, in the late onset cohort, the cumulative mortality
increased with time of diagnosis such that patients diagnosed
after 1980 had a significantly higher short term mortality than
did those diagnosed between 1970 and 1979 (fig 1⇓, bottom).
The 20 year cumulative mortality in the groups diagnosed in
1970-4, 1975-9, 1980-4, and 1985-9 was 4.4% (3.3% to 5.6%),
5.9% (4.6% to 7.1%), 6.5% (5.1% to 7.8%), and 7.9% (6.4%
to 9.4%).
In the early onset cohort, the standardised mortality ratio
decreased by 4.3% (2.8% to 5.8%) per year of diagnosis, after
adjustment for duration and age at onset of diabetes. The
standardised mortality ratio decreased from 4.3 (3.7 to 4.9) to
1.7 (0.9 to 2.9) (table 1⇓). In the late onset cohort, the increase
was 3.7% (2.4% to 5.0%) and the standardised mortality ratio
ranged between 2.5 and 3.0. During the first 20 years’ duration
in the early onset cohort, the standardised mortality ratio
decreased from 3.5 to 1.9, and in the late onset cohort it
increased from 1.4 to 2.9 (table 2⇓).
Figure 2⇓ shows the standardised mortality ratios by attained
age according to 5 year groups of age at onset. Interestingly,
the younger the age at onset of diabetes the longer the
standardised mortality ratios took to reach a peak. In general,
the peak in the standardised mortality ratio occurred when the
duration of diabetes was between 20 and 30 years. The only
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increase until 40 years of age despite more than 35 years’
duration. Mortality at or shortly after diagnosis in the groups
with age at onset of 5-9 and 15-19 years showed extreme
standardised mortality ratios before the age of 20 years.
However, this might simply be a result of very low mortality
in the background population at that young age. When the age
at onset was 20 years or more, the standardised mortality ratio
was much lower than that in the young age at onset groups. The
averagestandardisedmortalityratiosbyageatonsetofdiabetes
were 3.1 (2.3 to 4.0), 4.0 (3.4 to 4.6), 3.6 (3.2 to 4.1), 3.2 (2.9
to 3.7), 2.4 (2.1 to 2.8), and 2.7 (2.5 to 3.0) for the groups with
age at onset of 0-4, 5-9, 10-14, 15-19, 20-24, and 25-29 years.
Cause specific mortality
Mortality due to chronic complications of diabetes declined
from 10.0 (5.8 to 13.1) per 10 000 person years in patients who
were diagnosed as having diabetes in 1970-4 to 2.2 (0.9 to 4.5)
per 10 000 person years in those diagnosed in 1985-9 (P for
trend <0.001) in the early onset cohort (table 3⇓). In the late
onset cohort, the mortality did not decrease with year of
diagnosis; the corresponding rates were 13.0 (8.6 to 18.7) per
10 000 person years and 10.5 (6.7 to 15.7) per 10 000 person
years. Mortality due to acute complications of diabetes
(non-alcohol related) showed a non-significant tendency to
increase in the early onset cohort from 2.1 (0.8 to 4.6) per 10
000 person years to 4.1 (1.9 to 6.5) per 10 000 person years,
and acute diabetic complications accounted for 29% of the
deaths in those diagnosed in 1985-9 (table 4⇓). In the late onset
cohort, the increase was significant (P=0.03) and the
corresponding mortality rates were 0.5 (0.01 to 2.6) per 10 000
person years and 5.0 (2.5 to 9.0) per 10 000 person-years (table
3⇓).
Notably, the proportion of alcohol and drug related deaths was
unexpectedly high during the first 20 years in the early onset
cohort; one out of four deaths was associated with alcohol or
drugs. In the late onset cohort, a conspicuous increase in such
deaths occurred in those diagnosed after 1985 (table 4⇓). The
mortality rate increased 2.6 times from 6.0 (3.2 to 10.3) per 10
000 person years in patients diagnosed in 1970-4 to 15.5 (10.7
to 21.7) per 10 000 person years in those diagnosed in 1985-9
(P<0.001),andalcoholordrugsaccountedfor39%ofthedeaths.
The standardised mortality ratio for alcohol related deaths was
1.5 (1.1 to 1.9) in the early onset cohort and 1.5 (1.2 to 2.7) in
the late onset cohort. The standardised mortality ratio for
ischaemicheartdiseasewas17.4(12.6to22.1)intheearlyonset
cohort. Excess mortality due to ischaemic heart disease was
almostfourtimeshigherinwomenintheearlyonsetcohortand
three times higher in the late onset cohort compared with men.
The standardised mortality ratio for cerebrovascular disease
was 5.1 (2.3 to 7.9) in the early onset cohort and 2.8 (2.3 to 2.8)
in the late onset cohort. Women had a 2.4 times higher
standardised mortality ratio for cerebrovascular disease in the
earlyonsetcohortanda1.5timeshigherstandardisedmortality
ratio in the late onset cohort compared with men.
Altogether,110suicidesoccurredduringfollow-up.Halfofthe
suicides occurred during the first 20 years, accounting for
10-20% of the total deaths in the early onset cohort compared
with less than 10% in the late onset cohort. Mortality due to
suicide was increased only in women with early onset diabetes,
with a standardised mortality ratio of 3.3 (1.9 to 4.7). We found
an increasing trend in mortality due to suicide in the late onset
cohort (table 3⇓).
Discussion
Thisstudyprovidesacontemporarypictureofmortalityinearly
onset as well as late onset type 1 diabetes between 1970 and
2007 in Finland, the country with the highest incidence of type
1diabetesintheworld.
8 9Anencouragingfindingisthatsurvival
in the early onset cohort has improved in those patients most
recentlydiagnosedashavingdiabetes.Thiswasmainlybecause
of a decrease in mortality due to chronic complications of
diabetes. This encouraging finding in the early onset cohort is,
however, overshadowed by the unfavourable findings in the
late onset cohort, in which we saw an increasing trend in both
shorttermandlongtermstandardisedmortalityratios.However,
the cumulative mortality in the late onset cohort was very low
in the 1970s during the first 15 years’ duration of diabetes
(between 1% and 1.5%).
Comparison with other studies
Many studies have reported a decrease in mortality in type 1
diabetes, particularly due to a decrease in late diabetic
complicationsandcardiovasculardisease.
12 13Someotherstudies
have reported no changes in mortality.
14-16 This is partly a result
of differences between populations but also a result of
discrepanciesintheageatonsetanddurationofdiabetesaswell
as differences in time period between the studies. Many of the
studiesofmortalityhavecomparedpatientsdiagnosedafterand
beforethe1970s,
17 18butlittleevidenceexistsregardingchanges
in mortality during recent decades after many breakthroughs in
the management of diabetes or results in young adults.
19
The prognosis of patients with type 1 diabetes with regard to
diabetic complications has improved during recent decades
owing to great advances in diabetes care.
12 20-22 Consequently,
the incidence of end stage renal disease has also decreased
during the past four decades in Finland.
5 One could thus expect
improvements in survival regardless of the age at onset of
diabetes. This was not the case in this study, however, as
improvementinsurvivaloccurredonlyinthepatientswithearly
onset diabetes. Given that all patients with type 1 diabetes in
principle have access to the improvements in diabetes care, the
observed discrepancies between the early onset and late onset
cohortsmaybeduetodifferencesinmanagementpracticesand
psychosocial aspects and temporal changes in these.
Changes in diabetes management in Finland
The Finnish healthcare system has guaranteed equal healthcare
to everyone for a long time. With regard to diabetes, Finland
has had a nationally organised diabetes care system and insulin
has been available free of charge since 1965. Healthcare has,
however, limited means to reduce premature mortality if the
systemisbasedonrespondingtoacutephysicalproblemsrather
than preventive strategies and holistic care. According to the
report of the National Development Programme for the
Prevention and Care of Diabetes in Finland, geographical
disparities in the availability, organisation, and quality of
diabetes care have increased in Finland.
23 This has particularly
happenedsinceFinlandexperiencedadeepeconomicrecession
in the early 1990s, which caused considerable reductions in
healthcare spending and cuts in preventive health services in
the primary healthcare centres,
24 where care for patients with
adultonsetdiabetesispredominantlyarranged.Theimplemented
cuts may have caused healthcare to deteriorate in particular
among patients with late onset type 1 diabetes. Furthermore,
many healthcare centres have given up the diabetes nurse
system.
23 This may have resulted in irregular attendance at
diabetes clinics, a lack of longlasting patient-doctor-nurse
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patients with onset of diabetes at young adult ages.
Alcohol and drug related deaths
In the late onset cohort, the increase in alcohol and drug related
deaths as well as acute complications of diabetes outweighed
some reduction in chronic complications of diabetes. Alcohol
anddrugrelateddeathsaccountedfor39%ofdeathsat20years’
durationinpatientsdiagnosedbetween1985and1989.Alcohol
and drug related deaths were also high in the early onset group,
varying between 25% and 30%. The higher proportion in the
lateonsetcohortis,however,mostlyexplainedbytheolderage,
asalcoholrelateddeathsincreasewithincreasingageinFinland.
This is confirmed by comparing the standardised mortality
ratios;althoughtheabsolutenumbersofalcoholanddrugrelated
deaths were higher in the late onset cohort, the standardised
mortality ratio was similar in both cohorts indicating no
differences in excess mortality compared with the background
population.
The high proportion of, and increase in, alcohol related deaths
among patients with type 1 diabetes reflects that of the
background population. Since 2005, alcohol induced diseases
have been the most common cause of death in men and women
of working age (15-64 years) in Finland, exceeding the number
ofdeathsfromcardiovasculardisease(StatisticsFinland:www.
stat.fi).
In accordance with the results of this study, alcohol and drug
misuse also played an important role together with mental
dysfunctionorsuicideasthecauseofdeathsinSwedishpatients
with diabetes diagnosed between the ages of 15 and 34 years.
25
Likewise, drug misuse was an important cause of death in
patients with type 1 diabetes diagnosed in young adulthood in
the Yorkshire study.
26
However, the high numbers of alcohol and drug related deaths
in Finland are not straightforwardly comparable with those in
the other countries. The high rate found in Finland might be
due to high reliability of causes of death, as the medical death
certificate is issued only after autopsy, when this is done, with
all its accessory examinations completed.
27 The autopsy rate is
very high among patients with type 1 diabetes—about 80% in
this study. Postmortem toxicology allows the diagnosis of
alcoholordrugintoxicationmoreaccurately,soalcoholordrugs
as a cause of death may be found more frequently in Finland
than in other countries.
Acute diabetic complications
The increase in the proportion of acute complications of
diabetes—hypoglycaemia, ketoacidosis, or diabetic coma—in
the late onset cohort over time in this study is of concern.
Diabetic ketoacidosis has been reported to be the leading cause
early mortality, before the peak in chronic complications of
diabetes.
4 14 28 The EURODIAB mortality study reported that as
many as 35% of the deaths in children diagnosed after 1989
were due to acute complications.
4 Although acute diabetic
complications could be largely preventable, they are still an
importantcauseofdeath.Alcoholconsumptionisawellknown
risk factor for severe hypoglycaemia in type 1 diabetes,
29 and
an increase in both alcohol and drug related deaths and deaths
due to acute diabetic complications may be related.
Depression and suicides
People with type 1 diabetes have significantly higher rates of
depressionthandothosewithoutdiabetes.
30Wefrequentlyfound
adiagnosisofdepressioninthemedicalhistoryofpatientswho
died as a result of alcohol or drug misuse in this study. Heavy
drinking is often associated with clinically significant
depression.
31 Furthermore, depression is highly correlated with
suicidal ideation. Patients with type 1 diabetes have been found
to be at higher risk of suicide than people without diabetes in
some, but not all, studies.
32-35 Although more men than women
committed suicide, the standardised mortality ratio was
significant only in women with early onset diabetes. In
accordance with this, women had a higher risk of suicides in
studiesfromSloveniaandtheUnitedKingdom.
36 37Intoxication
with drugs was the most commonly used method of suicide in
women, whereas hanging and shooting were the predominant
methodsinmen.Easilyavailablediabetesrelatedmethodsmay
make women more vulnerable to suicide.
Effect of age at onset and duration of diabetes
on mortality
Not only the magnitude but also the peak in the standardised
mortality ratio varied according to age at onset of diabetes,
reflecting the effect of corresponding duration of diabetes. The
patterns seen in the peaks of standardised mortality ratios and
the effect of duration of diabetes resemble the model of
incidence of diabetic nephropathy and the variability of risk by
age at onset of diabetes. On average, the incidence of diabetic
nephropathy first increases linearly with duration of diabetes,
starting at five to 10 years’ duration, but after 20-25 years from
diagnosis the incident cases start to decline.
38 39 However, this
pattern is modified by the age at onset of diabetes. In the
youngest age at onset group, the standardised mortality ratio
did not reach a peak, probably because the duration of diabetes
was too short. This is in accordance with the population based
studies on end stage renal disease that have shown greatly
reduced or delayed risk of end stage renal disease in patients
with onset of diabetes before the age of 5 years.
5 40 This
prolonged peak in the standardised mortality ratio is
encouraging, as the age at onset of diabetes has decreased and
children with onset before the age of 5 are becoming more
common.
9 41 42
Strengths and limitations of study
The main strength of this study is that it is population based
with a large sample size, long follow-up time, and the ability
to compare differences in mortality not only by different time
of diagnosis but also between early onset and late onset type 1
diabetes. Mortality studies in type 1 diabetes should be
populationbasedandfirstidentifypatientswithtype1diabetes,
as in many countries the information on death certificates does
not allow identification of all patients with diabetes.
43
The main limitation is the lack of precise information about
type of diabetes for all patients. The classification of diabetes
inyoungadultsischallenging,andmisclassificationmayoccur.
However,weusedseveraldatasourcestoexcludepatientswith
secondary or type 2 diabetes. Furthermore, the vast majority of
people with diabetes below the age of 30 have type 1 diabetes.
Thus, we believe that misclassification of patients is not a
problem.
Obtaining precise estimates of cause specific mortality rates is
also challenging, because the underlying cause of death is not
always unequivocal. Patients with diabetes and several late
complications, mainly diabetic nephropathy, are at high risk of
cardiovasculardisease.Furthermore,acuterespiratoryinfections,
including pneumonia, tend to cluster in patients at high risk of
coronary heart disease and may even play a role in triggering
acutecoronarysyndromes.
44Patientswithdiabeticnephropathy
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death is pneumonia. If all these conditions were present, the
order in the classification in this study was infection,
cardiovascular disease, and diabetic nephropathy. The deaths
due to heart failure and infection may thus mask diabetic
nephropathy, and infection in turn may mask undetected
cardiovascular death. Therefore, we also grouped these causes
of death together and denoted them “any chronic diabetic
complications.”
Conclusions and policy implications
Inconclusion,wefoundimprovementinthesurvivalofpatients
with early onset type 1 diabetes followed from 1970 to 2007.
Improved survival in the early onset cohort was explained by a
decrease in chronic complications of diabetes during the first
20 years of diabetes. However, an alarming finding was that
both short term and long term trends showed an increase in the
standardised mortality ratios in patients diagnosed at the age of
15 to 29 years. The increase in mortality was due to an increase
in alcohol and drug related mortality and acute complications
of diabetes. This highlights the importance of permanent and
longlastingpatient-doctor-nurserelationships,closesupervision,
and guidance on the short term and long term effects of alcohol
in young people with type 1 diabetes, especially in our alcohol
permissive cultures.
Contributors: VH was responsible for study design, statistical analyses,
and writing of the manuscript. CF participated in regrouping causes of
death, interpretation of the results, and critical revision of the manuscript.
P-HG participated in regrouping causes of death, interpretation of the
results, and the writing and critical revision of the article. VH is the
guarantor.
Funding: This research was supported by grants from the Folkhälsan
Research Foundation, Wilhelm and Else Stockmann Foundation, and
Liv och Hälsa Foundation. The sponsors of the study had no role in the
design and conduct of the study or in the collection, management,
analysis, and interpretation of the data. The authors are independent
from the funders.
Competing interests: All authors have completed the unified competing
interest form at www.icmje.org/coi_disclosure.pdf (available on request
from the corresponding author) and declare that: this research was
supported by grants from the Folkhälsan Research Foundation, Wilhelm
and Else Stockmann Foundation, and Liv och Hälsa Foundation; the
authors have no relationship with companies that might have an interest
in the submitted work in the previous three years; and they have no
non-financial interests that may be relevant to the submitted work.
Ethical approval: This study was approved by the ethical committee of
the National Institute for Health and Welfare, Finland.
Data sharing: No additional data available.
1 Diabetes Epidemiology Research International Mortality Study Group. International
evaluation of cause-specific mortality and IDDM. Diabetes Care 1991;14:55-60.
2 Diabetes Epidemiology Research International Mortality Study Group. Major cross-country
differences in risk of dying for people with IDDM. Diabetes Care 1991;14:49-54.
3 Groop PH, Thomas MC, Moran JL, Wadén J, Thorn LM, Mäkinen VP, et al. The presence
and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes.
Diabetes 2009;58:1651-8.
4 Patterson CC, Dahlquist G, Harjutsalo V, Joner G, Feltbower RG, Svensson J, et al. Early
mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood
since 1989. Diabetologia 2007;50:2439-42.
5 Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C. Incidence of end-stage
renal disease in patients with type 1 diabetes. JAMA 2005;294:1782-7.
6 Harjutsalo V, Katoh S, Sarti C, Tajima N, Tuomilehto J. Population-based assessment of
familial clustering of diabetic nephropathy in type 1 diabetes. Diabetes 2004;53:2449-54.
7 Harjutsalo V, Maric C, Forsblom C, Thorn L, Wadén J, Groop PH. Sex-related differences
in the long-term risk of microvascular complications by age at onset of type 1 diabetes.
Diabetologia 2011;54:1992-9.
8 DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide
1990-1999. Diabet Med 2006;23:857-66.
9 Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in
Finnish children: a cohort study. Lancet 2008;371:1777-82.
10 Lammi N, Blomstedt PA, Moltchanova E, Eriksson JG, Tuomilehto J, Karvonen M. Marked
temporal increase in the incidence of type 1 and type 2 diabetes among young adults in
Finland. Diabetologia 2008;51:897-9.
11 Lammi N, Taskinen O, Moltchanova E, Notkola IL, Eriksson JG, Tuomilehto J, et al. A
high incidence of type 1 diabetes and an alarming increase in the incidence of type 2
diabetes among young adults in Finland between 1992 and 1996. Diabetologia
2007;50:1393-400.
12 Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural
history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes
Complications Study experience. Diabetes 2006;55:1463-9.
13 Allemann S, Saner C, Zwahlen M, Christ ER, Diem P, Stettler C. Long-term cardiovascular
and non-cardiovascular mortality in women and men with type 1 and type 2 diabetes
mellitus: a 30-year follow-up in Switzerland. Swiss Med Wkly 2009;139:576-83.
14 Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term
mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway.
Diabetologia 2006;49:298-305.
15 Burnet DL, Cooper AJ, Drum ML, Lipton RB. Risk factors for mortality in a diverse cohort
of patients with childhood-onset diabetes in Chicago. Diabetes Care 2007;30:2559-63.
16 Waernbaum I, Blohmé G, Östman J, Sundkvist G, Eriksson JW, Arnqvist HJ, et al. Excess
mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a
population-based study (DISS) in Sweden. Diabetologia 2006;49:653-9.
17 Nishimura R, LaPorte RE, Dorman JS, Tajima N, Becker D, Orchard TJ. Mortality trends
in type 1 diabetes: the Allegheny County (Pennsylvania) registry 1965-1999. Diabetes
Care 2001;24:823-7.
18 Asao K, Sarti C, Forsen T, Hyttinen V, Nishimura R, Matsushima M, et al. Long-term
mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland.
Diabetes Care 2003;26:2037-42.
19 Bruno G, Cerutti F, Merletti F, Novelli G, Panero F, Zucco C, et al. Short-term mortality
risk in children and young adults with type 1 diabetes: the population-based registry of
the province of Turin, Italy. Nutr Metab Cardiovasc Dis 2009;19:340-4.
20 Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, et al. Decreasing incidence
of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003;26:1258-64.
21 Astrup AS, Tarnow L, Rossing P, Pietraszek L, Riis Hansen P, Parving HH. Improved
prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study.
Kidney Int 2005;68:1250-7.
22 Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J. Declining incidence of severe
retinopathy and persisting decrease of nephropathy in an unselected population of type
1 diabetes—the Linkoping Diabetes Complications Study. Diabetologia 2004;47:1266-72.
23 Finnish Diabetes Association DC. Development programme for the prevention and care
of diabetes in Finland 2000-2010. Finnish Diabetes Association, 2001.
24 Forssas E, Keskimäki I, Reunanen A, Koskinen S. Widening socioeconomic mortality
disparity among diabetic people in Finland. Eur J Public Health 2003;13:38-43.
25 Wibell L, Nyström L, Östman J, Arnqvist H, Blohmé G, Lithner F, et al. Increased mortality
in diabetes during the first 10 years of the disease: a population-based study (DISS) in
Swedish adults 15-34 years old at diagnosis. J Intern Med 2001;249:263-70.
26 Feltbower RG, McKinney PA, Parslow RC, Stephenson CR, Bodansky HJ. Type 1 diabetes
in Yorkshire, UK: time trends in 0-14 and 15-29-year-olds, age at onset and
age-period-cohort modelling. Diabet Med 2003;20:437-41.
27 Lahti RA. From findings to statistics: an assessment of Finnish medical cause-of-death
information in relation to underlying-cause coding. Helsinki University Printing House,
2005.
28 Laing SP, Jones ME, Swerdlow AJ, Burden AC, Gatling W. Psychosocial and
socioeconomic risk factors for premature death in young people with type 1 diabetes.
Diabetes Care 2005;28:1618-23.
29 Richardson T, Weiss M, Thomas P, Kerr D. Day after the night before: influence of evening
alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diabetes Care
2005;28:1801-2.
30 Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid
depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-78.
31 Paljärvi T, Koskenvuo M, Poikolainen K, Kauhanen J, Sillanmäki L, Mäkelä P. Binge
drinking and depressive symptoms: a 5-year population-based cohort study. Addiction
2009;104:1168-78.
32 Dahlquist G, Kallen B. Mortality in childhood-onset type 1 diabetes: a population-based
study. Diabetes Care 2005;28:2384-7.
33 Bryden KS, Dunger DB, Mayou RA, Peveler RC, Neil HA. Poor prognosis of young adults
with type 1 diabetes: a longitudinal study. Diabetes Care 2003;26:1052-7.
34 Fuller-Thomson E, Sawyer JL. Lifetime prevalence of suicidal ideation in a representative
sample of Canadians with type 1 diabetes. Diabetes Res Clin Pract 2009;83:e9-11.
35 Goldston DB, Kovacs M, Ho VY, Parrone PL, Stiffler L. Suicidal ideation and suicide
attempts among youth with insulin-dependent diabetes mellitus. J Am Acad Child Adolesc
Psychiatry 1994;33:240-6.
36 Radobuljac MD, Bratina NU, Battelino T, Tomori M. Lifetime prevalence of suicidal and
self-injurious behaviors in a representative cohort of Slovenian adolescents with type 1
diabetes. Pediatr Diabetes 2009;10:424-31.
37 Roberts SE, Goldacre MJ, Neil HA. Mortality in young people admitted to hospital for
diabetes: database study. BMJ 2004;328:741-2.
38 Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy
in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia
1983;25:496-501.
39 Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural
history of nephropathy in type I diabetes. Am J Med 1985;78:785-94.
40 Möllsten A, Svensson M, Waernbaum I, Berhan Y, Schön S, Nyström L, et al. Cumulative
risk, age at onset and sex-specific differences for developing end-stage renal disease in
young patients with type 1 diabetes: a nationwide population based cohort study. Diabetes
2010;59:1803-8.
41 Tuomilehto J, Karvonen M, Pitkäniemi J, Virtala E, Kohtamäki K, Toivanen L, et al.
Record-high incidence of type I (insulin-dependent) diabetes mellitus in Finnish children.
Diabetologia 1999;42:655-60.
42 Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G. Incidence trends for childhood
type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a
multicentre prospective registration study. Lancet 2009;373:2027-33.
43 Mühlhauser I, Sawicki PT, Blank M, Overmann H, Richter B, Berger M. Reliability of
causes of death in persons with type I diabetes. Diabetologia 2002;45:1490-7.
44 Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute
coronary syndromes. Lancet Infect Dis 2010;10:83-92.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2011;343:d5364 doi: 10.1136/bmj.d5364 Page 5 of 11
RESEARCHWhat is already known on this topic
Type 1 diabetes is still associated with premature mortality due to both acute and chronic complications of diabetes
Few studies have compared trends in mortality between early onset and late onset type 1 diabetes
What this study adds
Survival of patients with early onset type 1 diabetes (age 0-14 years) has improved with time owing to a decrease in
chronic diabetic complications
Survival of patients with late onset type 1 diabetes (age 15-29 years) has deteriorated since the 1980s
Alcohol has become an important cause of death in patients with type 1 diabetes, and the proportion of acute diabetic
complications as a cause of death has increased in patients with late onset type 1 diabetes
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RESEARCHTables
Table 1| All cause standardised mortality ratios (SMRs) in early onset type 1 diabetes cohort (0-14 years) and late onset type 1 diabetes
cohort (15-29 years) diagnosed between 1970 and 1999 and followed from 1970 to 2007
P value for
risk ratio
Risk
ratio* SMR (95% CI)
Expected
No of
deaths Person years
Observed
No of
deaths
Mortality/100
000
Age range
(years)
Follow-up
range
(years)
Follow-up range
(period)
Diagnosis
cohort
Early onset
3.6 (3.3 to 3.9) 148.8 220 862 541 245 0-51 0-37 1970-2007 All
– 1.00 3.0 (2.7 to 3.4) 112.8 119 080 341 286 0-51 0-37 1970-2007 Men
0.002 1.33 5.5 (4.8 to 6.3) 36.0 101 781 200 197 0-51 0-37 1970-2007 Women
Subgroup†:
– 1.00 4.3 (3.7 to 4.9) 50.3 48 544 214 441 0-51 0-37 1970-2007 1970-4
NS 0.90 4.3 (3.7 to 5.1) 35.6 44 287 154 348 0-46 0-32 1975-2007 1975-9
<0.001 0.59 3.1 (2.5 to 3.8) 26.4 40 940 82 200 0-41 0-27 1980-2007 1980-4
<0.001 0.52 2.4 (1.7 to 3.2) 17.8 33 580 43 128 0-36 0-22 1985-2007 1985-9
NS 0.93 3.1 (2.2 to 4.3) 11.5 29 103 36 124 0-31 0-17 1990-2007 1990-4
<0.001 0.17 1.7 (0.9 to 2.9) 7.1 24 407 12 49 0-26 0-12 1995-2007 1995-9
Late onset
2.8 (2.6 to 3.0) 282.6 149 904 796 531 15-66 0-37 1970-2007 All
– 2.6 (2.4 to 2.8) 229.6 93 559 597 638 15-66 0-37 1970-2007 Men
<0.001 1.39 3.7 (3.2 to 4.3) 53.1 56 345 199 353 15-66 0-37 1970-2007 Women
Subgroup†:
– 1.00 2.9 (2.5 to 3.2) 94.7 36 511 279 764 15-66 0-37 1970-2007 1970-4
NS 0.90 2.5 (2.0 to 2.9) 78.7 33 840 198 585 15-61 0-32 1975-2007 1975-9
NS 1.17 2.9 (2.4 to 3.4) 47.6 27 051 137 506 15-56 0-27 1980-2007 1980-4
0.003 1.48 3.0 (2.4 to 3.6) 32.5 23 172 96 414 15-51 0-22 1985-2007 1985-9
<0.001 2.00 3.0 (2.3 to 3.9) 18.5 17 492 56 320 15-46 0-17 1990-2007 1990-4
<0.001 2.59 2.8 (1.9 to 3.9) 10.7 11 839 30 253 15-41 0-12 1995-2007 1995-9
NS=not significant.
*Adjusted for age at diagnosis and duration of diabetes.
†P value for trend <0.001.
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RESEARCHTable 2| All cause standardised mortality ratios (SMRs) at 20 years’ duration of diabetes in early onset type 1 diabetes cohort (0-14 years)
and late onset type 1 diabetes cohort (15-29 years) diagnosed between 1970 and 1989
P value for
risk ratio Risk ratio* SMR (95% CI)
ExpectedNo
of deaths
Person
years
Observed
No of
deaths
Mortality/100
000
Age range
(years)
Follow-up
range
(years)
Follow-up
range (period)
Diagnosis
subgroup
Early onset†
– 1.00 3.5 (2.7 to 4.4) 19.6 28 346 68 240 0-34 0-20 1970-94 1970-4
NS 0.81 3.4 (2.6 to 4.3) 18.9 29 696 64 216 0-34 0-20 1975-99 1975-9
0.02 0.64 3.0 (2.3 to 3.9) 18.7 32 373 57 176 0-34 0-20 1979-2004 1980-4
<0.003 0.36 1.9 (1.2 to 2.9) 10.1 19 219 19 99 0-34 0-20 1985-07 1985-9
Late onset†
– 1.00 1.4 (1.0 to 1.8) 35.1 21 924 49 223 15-49 0-20 1970-94 1970-4
NS 1.32 1.8 (1.4 to 2.3) 37.4 22 961 68 296 15-49 0-20 1975-99 1975-9
0.006 1.68 2.2 (1.8 to 2.8) 31.8 21 546 71 330 15-49 0-20 1979-2004 1980-4
<0.001 2.23 2.9 (2.2 to 3.7) 19.8 13 966 57 408 15-49 0-20 1985-2007 1985-9
NS=not significant.
*Adjusted for age at diagnosis and duration of diabetes.
†P value for trend <0.001.
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RESEARCHTable 3| Cause specific mortality per 10 000 person years in early onset type 1 diabetes cohort (0-14 years) and late onset type 1 diabetes
cohort (15-29 years) diagnosed between 1970 and 1989
P value for trend
Incidence/10 000 person years (95% CI)
Cause of death 1985-9 1980-4 1975-9 1970-4
Early onset cohort
NS 5.0 (2.9 to 8.1) 3.7 (1.9 to 6.5 ) 4.8 (2.6 to 8.0 ) 3.6 (1.7 to 6.6 ) All acute diabetic complications
NS 4.1 (1.9 to 6.5) 3.1 (1.5 to 5.7) 3.1 (1.4 to 5.8) 2.1 (0.8 to 4.6) Non-alcohol related acute diabetic complications
<0.001 2.2 (0.9 to 4.5) 4.3 (2.4 to 7.3) 6.8 (4.2 to 10.5) 10.0 (5.8 to 13.1) Any chronic diabetic complication
NS 1.3 (0.3 to 3.2) 3.1 (1.5 to 5.7) 4.1 (2.1 to 7.1) 3.6 (1.7 to 6.6) Suicides
0.06 3.4 (1.7 to 6.1) 4.3 (2.4 to 7.3) 6.1 (3.6 to 9.7) 7.1 (4.4 to 11.0) Alcohol/drug related deaths
0.003 12.8 (9.2 to 17.3) 17.7 (13.4 to 22.9) 21.8 (16.8 to 27.8) 24.2 (18.8 to 30.7) All deaths
Late onset cohort
0.04 6.4 (3.5 to 10.7) 5.6 (2.9 to 9.8) 5.33 (2.8 to 9.3) 1.9 (0.5 to 4.7) All acute diabetic complications
0.03 5.0 (2.5 to 9.0) 2.3 (0.8 to 5.5) 1.3 (0.3 to 3.9) 0.5 (0.01 to 2.6) Non-alcohol related acute diabetic complications
NS 10.5 (6.7 to 15.7) 15.4 (10.6 to 21.7) 12.9 (8.6 to 18.5) 13.0 (8.6 to 18.7) Any chronic diabetic complication
0.008 5.0 (1.0 to 6.0) 1.9 (0.5 to 4.8) 1.3 (0.3 to 3.9) 0.9 (0.1 to 3.3) Suicide
<0.001 15.5 (10.7 to 21.7) 9.8 (6.1 to 15.0) 6.7 (3.7 to 11.0) 6.0 (3.2 to 10.3) Alcohol/drug related deaths
<0.001 40.1 (32.2 to 49.5) 32.7 (25.5 to 41.3) 29.8 (23.1 to 37.8) 22.7 (16.8 to 30.0) All deaths
NS=not significant.
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RESEARCHTable 4| Classification of cause specific deaths in early onset type 1 diabetes cohort (0-14 years) and late onset type 1 diabetes cohort
(15-29 years) diagnosed between 1970 and 1989
No (%)
Cause of death 1985-9 1980-4 1975-9 1970-4
(n=41) (n=57) (n=64) (n=68) Early onset cohort
Acute diabetic complications (DKA, hypoglycaemia, hyperosmolar coma):
4 (10) 2 (4) 5 (8) 4 (6) Alcohol/drug related
12 (29) 10 (18) 9 (14) 6 (9) Other
1 (2) 3 (5) 4 (6) 7 (10) Chronic diabetic complications
Cardiovascular:
3 (7) 3 (5) 5 (8) 7 (10) Acute myocardial infarction
0 0 0 0 Cerebrovascular disease
1 (2) 2 (4) 3 (5) 4 (6) Other
2 (5) 6 (11) 8 (13) 7 (10) Infection (septicaemia, pneumonia, myocarditis, other infections)
7 (17) 14 (25) 20 (31) 25 ( 37) Any chronic diabetic complication
0 3 (5) 4 (6) 4 (6) Neoplasm
2 (5) 0 2 (3) 3 (4) Sudden death
Suicide:
3 (7) 6 (11) 5 (8) 7 (10) Alcohol/drug related
1 (2) 4 (7) 7 (11) 3 (4) Other
Accidents (not intoxications):
1 (2) 5 (9) 6 (9) 4 (6) Alcohol/drug related
6 (15) 10 (18) 2 (3) 5 (7) Other
2 (5) 1 (2) 2 (3) 5 (7) Other alcohol/drug related (alcoholic cirrhosis of liver, alcohol/drug intoxications)
3 (7) 2 (4) 2 (3) 2 (3) Other cause
11 (27) 14 (25) 18 (28) 20 (29) All alcohol/drug related deaths
(n=88) (n=70) (n=67) (n=48) Late onset cohort
Acute diabetic complications (DKA, hypoglycaemia, hyperosmolar coma):
3 (3) 7 (10) 9 (13) 3 (6) Alcohol/drug related
11 (13) 5 (7) 3 (4) 1 (2) Other
4 (5) 5 (7) 5 (7) 4 (8) Chronic diabetic complications
Cardiovascular
11 (13) 7 (10) 14 (21) 9 (19) Acute myocardial infarction
1 (1) 2 (3) 0 5 (10) Cerebrovascular disease
3 (3) 6 (9) 0 0 Other
4 (5) 13 (19) 10 (15) 10 (21) Infection (septicaemia, pneumonia, myocarditis, other infections)
23 (26) 33 (47) 29 (43) 28 (58) Any chronic diabetic complication
5 (6) 3 (4) 5 (7) 3 (6) Neoplasm
5 (6) 1 (1) 1 (1) 2 (4) Sudden death
Suicide:
9 (10) 4 (6) 2 (3) 2 (4) Alcohol/drug related
2 (2) 0 1 (1) 0 Other
Accidents (not intoxications):
1 (1) 2 (3) 1 (1) 1 (2) Alcohol/drug related
3 (3) 4 (6) 6 (9) 0 Other
22 (25) 10 (14) 6 (9) 7 (15) Other alcohol/drug related (alcoholic cirrhosis of liver, alcohol/drug intoxications)
4 (5) 1 (1) 4 (6) 1 (2) Other cause
34 (39) 21 (30) 15 (22) 13 (27) All alcohol/drug related deaths
DKA=diabetic ketoacidosis.
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RESEARCHFigures
Fig 1 Cumulative mortality in patients in Finland with type 1 diabetes diagnosed between 1970 and 1999: early onset cohort
(0-14 years) (top); late onset cohort (15-29 years) (bottom)
Fig 2 Predicted standardised mortality ratios according to 5 year age at onset groups
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